(Q46548988)

English

Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat.

scientific article published on 10 June 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18542928

Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat. (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18542928

4

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18542928

author name string

Zo Rakotoniaina

1

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18542928

Pascal Guerard

2

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18542928

Frédéric Lirussi

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18542928

Monique Dumas

5

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18542928

Françoise Goirand

6

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18542928

Marc Bardou

7

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18542928

publication date

10 June 2008

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18542928

Naunyn-Schmiedeberg's Archives of Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18542928

378

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18542928

3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18542928

241-251

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18542928

Attenuation of chronic hypoxic pulmonary hypertension by simvastatin

1 reference

https://api.crossref.org/works/10.1007%2FS00210-008-0298-3

21 January 2018

Hypoxic induction of cox-2 regulates proliferation of human pulmonary artery smooth muscle cells

1 reference

https://api.crossref.org/works/10.1007%2FS00210-008-0298-3

21 January 2018

Long-term outcome with first-line bosentan therapy in idiopathic pulmonary arterial hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cardioprotection of the late phase of ischemic preconditioning is enhanced by postconditioning via a COX-2-mediated mechanism in conscious rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Celecoxib, a cyclooxygenase-2 inhibitor, reduces neointimal hyperplasia through inhibition of Akt signaling

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Hypoxic vasoconstriction of rat main pulmonary artery: role of endogenous nitric oxide, potassium channels, and phosphodiesterase inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rofecoxib [Vioxx, MK-0966; 4-(4'-methylsulfonylphenyl)-3-phenyl-2-(5H)-furanone]: a potent and orally active cyclooxygenase-2 inhibitor. Pharmacological and biochemical profiles

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of the selective COX-2 inhibitors celecoxib and rofecoxib on human vascular cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simvastatin causes endothelial cell apoptosis and attenuates severe pulmonary hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An imbalance between the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Primary pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Statin therapy, alone or with rapamycin, does not reverse monocrotaline pulmonary arterial hypertension: the rapamcyin-atorvastatin-simvastatin study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A role for cyclooxygenase in aging-related changes of beta-adrenoceptor-mediated relaxation in rat aortas

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

How valid are animal models to evaluate treatments for pulmonary hypertension?

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prostacyclin, thromboxane A2, and hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential effects of selective cyclooxygenase-2 inhibitors on endothelial function in salt-induced hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective COX-2 inhibitors and renal injury in salt-sensitive hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammation in pulmonary arterial hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac hypertrophy induced by prostaglandin F(2alpha) may be mediated by calcineurin signal transduction pathway in rats.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, placebo-controlled, double-blind, crossover study to evaluate the efficacy of oral sildenafil therapy in severe pulmonary artery hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of acute and chronic hypoxia on rat lung cyclooxygenase

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cytotoxicity of celecoxib towards cardiac myocytes is cyclooxygenase-2 independent

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of chronic intake of NSAIDs and cyclooxygenase 2-selective inhibitors on esophageal cancer incidence

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclooxygenase-2 inhibition increases mortality, enhances left ventricular remodeling, and impairs systolic function after myocardial infarction in the pig.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathology and aspects of pathogenesis in pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Simvastatin treatment of pulmonary hypertension: an observational case series

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term outcome in pulmonary arterial hypertension patients treated with subcutaneous treprostinil

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of celecoxib on cardiovascular events and blood pressure in two trials for the prevention of colorectal adenomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of cyclooxygenase-2 in the generation of vasoactive prostanoids in the rat pulmonary and systemic vascular beds

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Celecoxib inhibits proliferation of retinal pigment epithelial and choroid-retinal endothelial cells by a cyclooxygenase-2-independent mechanism

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-1beta, transforming growth factor-beta1, and bradykinin attenuate cyclic AMP production by human pulmonary artery smooth muscle cells in response to prostacyclin analogues and prostaglandin E2 by cyclooxygenase-2 induction and downregula

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intravascular thrombosis after hypoxia-induced pulmonary hypertension: regulation by cyclooxygenase-2.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Angiotensin-converting enzyme inhibitor preserves p21 and endothelial nitric oxide synthase expression in monocrotaline-induced pulmonary arterial hypertension in rats

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Non-lipid effects of statins: emerging new indications

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Celecoxib dilates guinea-pig coronaries and rat aortic rings and amplifies NO/cGMP signaling by PDE5 inhibition.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monocrotaline pyrrole induces apoptosis in pulmonary artery endothelial cells.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary arterial hypertension in mixed connective tissue disease: successful treatment with Iloprost.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhalation of nebulized nitroglycerin, a nitric oxide donor, for the treatment of pulmonary hypertension induced by high pulmonary blood flow

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pulmonary arterial hypertension in France: results from a national registry

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The cyclooxygenase-2-selective inhibitors rofecoxib and celecoxib prevent colorectal neoplasia occurrence and recurrence

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclooxygenase-2 (COX-2)-independent anticarcinogenic effects of selective COX-2 inhibitors

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The endocannabinoid arachidonyl ethanolamide (anandamide) increases pulmonary arterial pressure via cyclooxygenase-2 products in isolated rabbit lungs

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Celecoxib modulates hypertrophic signalling and prevents load-induced cardiac dysfunction

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inhibition of serotonin-induced mitogenesis, migration, and ERK MAPK nuclear translocation in vascular smooth muscle cells by atorvastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclooxygenase-2 and an early stage of chronic hypoxia-induced pulmonary hypertension in newborn pigs

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of chronic hypoxic pulmonary hypertension by simvastatin

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A factor preventing the major head protein of bacteriophage T4 from random aggregation

1 reference

https://pubmed.ncbi.nlm.nih.gov/18542928

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00210-008-0298-3

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18542928

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 December 2017

http://europepmc.org/abstract/MED/18542928

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46548988&oldid=2207942429"